The FDA issued a public health advisory for Mifepristone (trade name Mifeprex, also known as RU-486) following four deaths associated with the use of the drug.
Jill Stanek explains that that problem is related to the drug Cytotec, which is necessarily taken in combination with RU-486 despite known health risks. In fact, Stanek reveals that Searle, the manufacturer of Cytotec, issued a letter warning against off-label use in August 2000 (which the FDA posted on its site) two months before the FDA approved RU-486.
Judie Brown, president of the American Life League, reacted to the reports of recent RU-486 related deaths by calling for the government to withdraw it from the market.
"This drug has no beneficial qualities," said Brown. "Its one and only purpose is to end the life of a preborn child. As we are seeing more and more, this deadly concoction not only kills the baby, but can kill the mother as well. The abortion industry seems to consider these women's lives meaningless and irrelevant in its quest for greater profits and more dead babies."
Danco Laboratories LLC, the company that produces the drug, is updating its warning labels. "A warning label will not do a thing to prevent more deaths," said Brown. "The only solution is to remove this killing mechanism from the market immediately so that no more women and innocent babies lose their lives."
JivinJ adds: You can read some of the adverse effects reports that the abortion drug cocktail has had on women at the Concerned Women for America's webpage.
Talk Back - leave a comment